Clinical Value of Neutrophil-to-Lymphocyte Ratio in Endometriosis

In: Chung-Hua Fu Ch'an K'o Tsa Chih · 2012 · vol. 8(3) , pp. 317–319 · doi:10.3877/cma.j.issn.1673-5250.2012.03.019 · W3029580084
article OA: closed CC0
Full text JSON View on OpenAlex View at publisher
AI-generated summary by claude@2026-06, 2026-06-08

Neutrophil-to-lymphocyte ratio and CA125 levels were significantly higher in endometriosis patients compared to those with benign ovarian tumors or healthy controls, suggesting NLR's value in screening and early diagnosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-10 · read from full text

This study investigated the clinical value of neutrophil-to-lymphocyte ratio (NLR) for diagnosing endometriosis in 90 women with tissue-pathology confirmed endometriosis who underwent surgery, compared with 60 women with benign ovarian tumors and 60 healthy controls; endometriosis cases were staged using the revised American Fertility Society criteria, creating ≤II and ≥III subgroups. Serum CA125 and NLR were measured from fasting cubital venous blood. NLR values and CA125 levels were significantly higher in the endometriosis group than in both comparison groups, but within the endometriosis cohort NLR did not differ significantly between ≤II and ≥III stages, whereas CA125 did show significant stage-related differences. This paper concludes that NLR may have value for endometriosis primary screening and early diagnosis, with the main limitation being the absence of a demonstrated stage-discriminating role for NLR. This paper is centrally about endometriosis — it evaluates NLR as an inflammatory biomarker to aid diagnosis of endometriosis and compares it with CA125 across disease stage.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Objective To explore the clinical value of neutrophil-to-lymphocyte ratio (NLR) in endometriosis(EMs). Methods From January 2006 to December 2010, 90 patients with EMs, 60 patients with benign ovarian tumors, 60 healthy women were included in the study. They were divided into EMs group[n=90, with ≤stageⅡsubgroup(n=36)and ≥ stage Ⅲ subgroup(n=54)], benign ovarian tumors group(n=60)and control group(n=60). NLR value and serum CA125 level were measured and calculated. The study protocol was approved by the Ethical Review Board of Investigation in Human Being of Chaohu First Hospital. Informed consent was obtained from each patients. Results The NLR value and CA125 level in EMs group were significantly higher than those in benign ovarian tumor group and control group, respectively (P<0.05). There had significant differences of CA125 level and the positive rate between ≤stageⅡsubgroup and ≥ stage Ⅲ subgroup in EMs group. And there had no significant difference in NLR value and the positive rate between two subgroups. Conclusions NLR value is a new inflammatory target, which has a good value on EMs primary screening and early diagnosis. Key words: endometriosis; neutrophil-to-lymphocyte ratio; CA125
Full text 4,843 characters · extracted from oa-doi-fallback · 4 sections · click to expand

Objective

To explore the clinical value of neutrophil-to-lymphocyte ratio (NLR) in endometriosis(EMs).

Methods

From January 2006 to December 2010, 90 patients with EMs, 60 patients with benign ovarian tumors, 60 healthy women were included in the study. They were divided into EMs group[n=90, with ≤stageⅡsubgroup(n=36)and ≥ stage Ⅲ subgroup(n=54)], benign ovarian tumors group(n=60)and control group(n=60). NLR value and serum CA125 level were measured and calculated. The study protocol was approved by the Ethical Review Board of Investigation in Human Being of Chaohu First Hospital. Informed consent was obtained from each patients.

Results

The NLR value and CA125 level in EMs group were significantly higher than those in benign ovarian tumor group and control group, respectively (P<0.05). There had significant differences of CA125 level and the positive rate between ≤stageⅡsubgroup and ≥ stage Ⅲ subgroup in EMs group. And there had no significant difference in NLR value and the positive rate between two subgroups.

Conclusions

NLR value is a new inflammatory target, which has a good value on EMs primary screening and early diagnosis. | [1] | Gagne D, Rivard M, Page M, et al.Development of a nonsurgical diagnostic tool for endometriosis based on the detection of endometrial leukocyte subsets and serum CA125 levels[J]. Fertil Steril, 2003, 80(4):876-885. | | [2] | Jilm a B, Blann A, Pimerstorfer T, et al. Regulation of adhesion molecules during human endotoxemia. No acute effects of aspirin[J].Am J Respir Crit Care Med, 1999, 159(3):857-863. | | [3] | Cho S, Cho H, Nam A, et al. Neutrophil-to-lymphocyte ratio as an adjunct to CA125 for the diagnosis of endometriosis[J].Fertil Steril, 2008, 90(6):2073-2079. | | [4] | Liu DC, Zhang CB, Lu BY, et al.Study advance in immunological pathogenesis of endometriosis[J]. Heilongjiang Med Pharm, 2009, 32(4):87-88. | | [5] | Shi J, Di W.Clinical significance of serum CA125 for endometriosis diagnosis[J]. Guangdong Med J, 2008, 29(5):718-720. | | [6] | | | [7] | Abrao MS, Podgaec S, Filho BM, et al. The use of biochemical markers in the diagnosis of pelvic endometriosis[J]. Hum Reprod, 1997, 12(11):2523-2527. | | [8] | Tan XJ, Lang JH, Liu DY, et al. Expression of vascular endothelial growth factor and thrombospondin-1 mRNA in patients with endometriosis[J].Fertil Steril, 2002, 78(1):148-153. | | [1] | 朱成美, 赵巧梅, 邓学东. 经阴道超声联合生理盐水灌注直肠子宫陷凹对腹膜型子宫内膜异位症的诊断价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(01): 32-36. | | [2] | 乔林. 子宫内膜异位症鉴别诊断病例分享[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(02): 248-. | | [3] | 何欣林, 阎昊铮, 赵亦非, 江彩霞, 李征宇. 新辅助化疗联合间歇性肿瘤细胞减灭术对上皮性卵巢癌患者预后及血清学与影像学指标对患者预后的预测价值[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(01): 47-57. | | [4] | 魏丽坤, 张旭红, 罗营, 薛凤霞, 王颖梅, 宋学茹, 田丽娜, 张艳芳, 王艳霞, 田文艳. 卵巢子宫内膜异位囊肿发生恶变并发盆腔脓肿1例并文献复习[J/OL]. 中华妇幼临床医学杂志(电子版), 2023, 19(06): 696-702. | | [5] | 罗丹, 孔为民, 陈姝宁, 赵小玲, 谢云凯. 子宫内膜异位症患者在位及异位内膜上皮细胞-间充质转化相关生物标志物的变化[J/OL]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 530-539. | | [6] | 成军霞, 梅馨方, 青刚, 许郭华. NLR与qSOFA评分对老年重症肺炎预后的临床意义[J/OL]. 中华肺部疾病杂志(电子版), 2023, 16(05): 703-705. | | [7] | 胡启明, 鄢潇, 尤志学, 黄骁昊. 经瘢痕处单孔腹腔镜下切除多病灶腹壁子宫内膜异位症[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(05): 314-317. | | [8] | 张蕾, 彭超, 周应芳. 直肠阴道隔子宫内膜异位症腹腔镜手术技巧[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(05): 257-261. | | [9] | 何慧玲, 鲁祖斌, 冯嘉莉, 梁声强. 术前外周血NLR和PLR对结肠癌术后肝转移的影响[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 682-687. | | [10] | 芦煜, 李振宇, 吴承东, 周仲伍. 肛周子宫内膜异位症一例报告[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 431-434. | | [11] | 陈娟, 邓静敏. 胸部子宫内膜异位综合征的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(01): 96-100. | | [12] | 王丁然, 迟洪滨. 自身免疫甲状腺炎对子宫内膜异位症患者胚胎移植结局的影响[J/OL]. 中华临床医师杂志(电子版), 2023, 17(06): 682-688. | | [13] | 洪凡, 陈敦金, 傅洋, 梁新月, 吴毅, 王晓怡. 体外受精-胚胎移植妊娠合并前置胎盘临床研究[J/OL]. 中华产科急救电子杂志, 2024, 13(03): 176-182. | | [14] | 张杰, 纪东华. 预测和评估外周动脉疾病严重程度理化指标的研究现状[J/OL]. 中华介入放射学电子杂志, 2024, 12(02): 176-179. | | [15] | 席静妮, 李娜, 张琪. 中性粒细胞与淋巴细胞比值对老年重症社区获得性肺炎进展为脓毒症的预测价值[J/OL]. 中华老年病研究电子杂志, 2024, 11(03): 28-31. | | 阅读次数 | ||||| | 全文 | | |||| | 摘要 | | |||| 版权所有 中华医学会 中华医学电子音像出版社有限责任公司 京ICP备14006079号-1 网络出版服务许可证:(署)网出证(京)字第075号 AI 小 编 AI小编

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK